[go: up one dir, main page]

GB0920721D0 - An orally administered anthelmintic unit dose tablet and process for the preparation thereof - Google Patents

An orally administered anthelmintic unit dose tablet and process for the preparation thereof

Info

Publication number
GB0920721D0
GB0920721D0 GBGB0920721.8A GB0920721A GB0920721D0 GB 0920721 D0 GB0920721 D0 GB 0920721D0 GB 0920721 A GB0920721 A GB 0920721A GB 0920721 D0 GB0920721 D0 GB 0920721D0
Authority
GB
United Kingdom
Prior art keywords
preparation
unit dose
orally administered
dose tablet
anthelmintic unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0920721.8A
Other versions
GB2475701B (en
GB2475701A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BURKE MICHAEL H
Original Assignee
BURKE MICHAEL H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BURKE MICHAEL H filed Critical BURKE MICHAEL H
Priority to GB0920721A priority Critical patent/GB2475701B/en
Publication of GB0920721D0 publication Critical patent/GB0920721D0/en
Publication of GB2475701A publication Critical patent/GB2475701A/en
Application granted granted Critical
Publication of GB2475701B publication Critical patent/GB2475701B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB0920721A 2009-11-26 2009-11-26 A process for the preparation of an orally administered anthelmintic unit dose tablet Expired - Fee Related GB2475701B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0920721A GB2475701B (en) 2009-11-26 2009-11-26 A process for the preparation of an orally administered anthelmintic unit dose tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0920721A GB2475701B (en) 2009-11-26 2009-11-26 A process for the preparation of an orally administered anthelmintic unit dose tablet

Publications (3)

Publication Number Publication Date
GB0920721D0 true GB0920721D0 (en) 2010-01-13
GB2475701A GB2475701A (en) 2011-06-01
GB2475701B GB2475701B (en) 2011-10-19

Family

ID=41572721

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0920721A Expired - Fee Related GB2475701B (en) 2009-11-26 2009-11-26 A process for the preparation of an orally administered anthelmintic unit dose tablet

Country Status (1)

Country Link
GB (1) GB2475701B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112220769A (en) * 2020-08-13 2021-01-15 浙江海正动物保健品有限公司 Milbemycin oxime praziquantel flavored tablet and preparation method thereof
CN114306268A (en) * 2021-12-28 2022-04-12 恒诚制药集团淮南有限公司 Praziquantel film coating preparation and preparation method thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ708741A (en) * 2012-12-19 2019-11-29 Bayer Animal Health Gmbh Tablets with improved acceptance and good storage stability
CA3049952A1 (en) 2017-07-26 2019-01-31 Tgx Soft Chew, Llc Starch-free soft chew for veterinary applications

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3705227A1 (en) * 1987-02-19 1988-09-01 Bayer Ag ANTHELMINTHIC ACTIVE COMBINATIONS
WO2005016356A1 (en) * 2003-08-08 2005-02-24 The Hartz Mountain Corporation Improved anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
WO2006013444A1 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation
CN101119709A (en) * 2005-02-15 2008-02-06 惠氏公司 Orally bioavailable CCI-779 formulation
US7348027B2 (en) * 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
AR065802A1 (en) * 2007-03-22 2009-07-01 Schering Corp FORMULATIONS OF TABLETS CONTAINING SALTS OF 8- [(1- (3,5- BIS- (TRIFLUOROMETIL) FENIL) -ETOXI) - METHYL) -8- PHENYL -1, 7- DIAZA- SPIRO [4,5] DECAN - 2- ONA AND TABLETS PREPARED FROM THESE

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112220769A (en) * 2020-08-13 2021-01-15 浙江海正动物保健品有限公司 Milbemycin oxime praziquantel flavored tablet and preparation method thereof
CN114306268A (en) * 2021-12-28 2022-04-12 恒诚制药集团淮南有限公司 Praziquantel film coating preparation and preparation method thereof

Also Published As

Publication number Publication date
GB2475701B (en) 2011-10-19
GB2475701A (en) 2011-06-01

Similar Documents

Publication Publication Date Title
ZA200906347B (en) Solid pharmaceutical and vaccine dose
ZA201109395B (en) Solid drug tablets for implantable drug delivery devices
ZA201006029B (en) Pharmaceutical dosage form
IL206159A0 (en) Oral pharmaceutical dosage forms
EP2481739A4 (en) Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
SI2464342T1 (en) Pharmaceutical formulations against drug misuse
EP2429506A4 (en) Coated pharmaceutical capsule dosage form
EP2392307A4 (en) Drug solution dose controller
IL217762A0 (en) Pharmaceutical formulation
EP2456471A4 (en) Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof
EP2665471A2 (en) Controlled release oral pharmaceutical dosage forms comprising mgbg
EP2424509A4 (en) Fixed dose drug combination formulations
ZA200903858B (en) Pharmaceutical dosage form
ZA201105572B (en) Pharmaceutical composition for oral administration
EP2263637A4 (en) Medicinal preparation for oral administration
IL219617A0 (en) Pharmaceutical solid dosage form
GB2455875B (en) A process for the preparation of an orally administered unit dose tablet
IL218643A0 (en) Orally disintegrating pharmaceutical dosage form containing aripiprazole
GB0703674D0 (en) A Process For The Preparation of an Orally Administered Unit Dose Tablet
GB0920721D0 (en) An orally administered anthelmintic unit dose tablet and process for the preparation thereof
HU0900482D0 (en) Pharmaceutical formulation for oral administration
GB2437054B (en) A process for the preparation of an orally administered unit dose tablet
HK1175118A (en) Pharmaceutical solid dosage form
IL200682A (en) Device for administering medicine
HK1149191A (en) Pharmaceutical dosage form

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20141126